Research And Development
Research and development (R&D) is work to create or improve products and processes. Covers R&D accounting under GAAP and IFRS, R&D intensity and tax credits.
Contents
Research and development (R&D) is the work a company does to discover new knowledge and turn it into new or improved products, processes or services. US GAAP requires most R&D costs to be expensed as incurred, while IFRS requires development costs to be capitalized once a project meets specific criteria, a difference that can change reported profit materially. Many governments also offer tax credits for qualifying R&D.
Types of research and development
- Basic research: work to gain new knowledge without a particular commercial product in mind.
- Applied research: research aimed at a particular practical goal, such as a new material or drug compound.
- Development: turning research findings into a plan or design for a new or substantially improved product or process, including building and testing prototypes.
Routine work is not R&D under the accounting standards. Market research, quality control testing, routine product changes and ongoing efforts to refine an existing product are excluded.
How R&D is accounted for under US GAAP
ASC 730 requires R&D costs to be expensed as incurred because their future benefits are too uncertain to record as an asset. That includes researchers' salaries, materials used, contract research and an allocation of overhead. The R&D line on the income statement is typically an operating expense. The main exceptions are:
- Equipment and facilities with alternative future uses are capitalized and depreciated, and the depreciation is charged to R&D expense.
- Software has its own rules. Costs of software to be sold or licensed can be capitalized once technological feasibility is established, and some costs of developing internal-use software can be capitalized once specific criteria are met.
- In-process R&D acquired in a business combination is recorded at fair value as an indefinite-lived intangible asset until the project is finished or abandoned.
How R&D is accounted for under IFRS
IAS 38 splits a project into a research phase and a development phase. Research costs are always expensed. Development costs must be capitalized as an intangible asset once the company can demonstrate all of the following:
- The technical feasibility of completing the asset.
- Its intention to complete the asset and use or sell it.
- Its ability to use or sell it.
- How the asset will generate probable future economic benefits, such as a market for its output.
- Adequate technical, financial and other resources to complete it.
- The ability to measure the development spending reliably.
Spending before the criteria are met is expensed and cannot be capitalized later. Capitalized development costs are amortized over the asset's useful life once it is available for use.
R&D accounting example
A company with revenue of $25,000,000 spends $2,000,000 on a new product that is not software: $800,000 in the research phase, $300,000 on development before the IFRS criteria are met and $900,000 on development afterwards.
- US GAAP: the full $2,000,000 is expensed as R&D in the year.
- IFRS: $1,100,000 ($800,000 + $300,000) is expensed and $900,000 is capitalized as an intangible asset. If the product launches and the asset is amortized over five years, the company records $180,000 of amortization a year.
In the year of spending, operating profit under IFRS is $900,000 higher than under US GAAP. In later years it is lower by the amortization charge, so the difference is mostly one of timing.
R&D intensity
R&D intensity = R&D expense ÷ Revenue
R&D intensity measures how much of each dollar of sales a company puts back into research and development. In the example, it is $2,000,000 ÷ $25,000,000 = 8.0% under US GAAP but only $1,100,000 ÷ $25,000,000 = 4.4% under IFRS, because IFRS moved $900,000 onto the balance sheet. When comparing companies across frameworks, add capitalized development back to R&D expense. Intensity varies greatly by industry: pharmaceutical, semiconductor and software companies spend far more of their revenue on R&D than retailers or utilities.
R&D tax credits and deductions
- United States: the federal credit for increasing research activities, commonly called the R&D tax credit, reduces tax for qualifying research expenses, and many states offer their own credits.
- Canada: the Scientific Research and Experimental Development (SR&ED) program provides federal investment tax credits, with enhanced credits, largely refundable in cash, for qualifying Canadian-controlled private corporations, and provinces add their own incentives.
- Deducting R&D costs: the US rules on whether research costs can be deducted immediately or must be capitalized and amortized for tax purposes have changed more than once in recent years. Consult current law, or a tax adviser, before modeling the tax effect.
Because a credit cuts tax dollar for dollar, it is worth more than a deduction of the same amount, which saves only the amount multiplied by the tax rate (see tax shield). Credits are a common reason a company's effective tax rate falls below the statutory rate.
R&D vs. capital expenditures
Capital expenditures buy or improve physical assets such as plant and equipment, which are capitalized and depreciated. R&D is mostly expensed even though it is also an investment in future earnings, which makes R&D-heavy companies look less profitable and less asset-intensive than their economics suggest. Some analysts capitalize R&D in their own models to put such companies on a comparable footing with capital-intensive ones.
Frequently asked questions
Is R&D an expense or an asset?
Under US GAAP, R&D is almost always an expense, with exceptions for particular software costs and equipment with alternative uses. Under IFRS, research is an expense, but development spending that meets the IAS 38 criteria is capitalized as an intangible asset.
Is R&D an operating expense?
Yes. Expensed R&D is reported within operating expenses, often on its own line, so it reduces operating income and EBIT.
How does R&D accounting affect EBITDA?
Expensed R&D reduces EBITDA, while the amortization of capitalized development costs is excluded from it. As a result, an IFRS company that capitalizes development can show higher EBITDA than an otherwise identical US GAAP company.
What does not count as R&D?
Market research, routine quality testing, routine or seasonal product changes and efficiency studies are excluded. So is R&D a company does for customers under contract, which is a cost of the revenue earned.